GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » GoodRx Holdings Inc (NAS:GDRX) » Definitions » Gross Profit

GoodRx Holdings (GoodRx Holdings) Gross Profit : $701.5 Mil (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is GoodRx Holdings Gross Profit?

GoodRx Holdings's gross profit for the three months ended in Mar. 2024 was $185.4 Mil. GoodRx Holdings's gross profit for the trailing twelve months (TTM) ended in Mar. 2024 was $701.5 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. GoodRx Holdings's gross profit for the three months ended in Mar. 2024 was $185.4 Mil. GoodRx Holdings's Revenue for the three months ended in Mar. 2024 was $197.9 Mil. Therefore, GoodRx Holdings's Gross Margin % for the quarter that ended in Mar. 2024 was 93.70%.

GoodRx Holdings had a gross margin of 93.70% for the quarter that ended in Mar. 2024 => Durable competitive advantage

During the past 6 years, the highest Gross Margin % of GoodRx Holdings was 97.58%. The lowest was 91.08%. And the median was 94.18%.

Warning Sign:

GoodRx Holdings Inc gross margin has been in long-term decline. The average rate of decline per year is -1.5%.


GoodRx Holdings Gross Profit Historical Data

The historical data trend for GoodRx Holdings's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GoodRx Holdings Gross Profit Chart

GoodRx Holdings Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial 374.21 521.11 698.71 701.48 683.34

GoodRx Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 167.29 173.34 161.24 181.47 185.41

Competitive Comparison of GoodRx Holdings's Gross Profit

For the Health Information Services subindustry, GoodRx Holdings's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GoodRx Holdings's Gross Profit Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, GoodRx Holdings's Gross Profit distribution charts can be found below:

* The bar in red indicates where GoodRx Holdings's Gross Profit falls into.



GoodRx Holdings Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

GoodRx Holdings's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=750.265 - 66.925
=683.3

GoodRx Holdings's Gross Profit for the quarter that ended in Mar. 2024 is calculated as

Gross Profit (Q: Mar. 2024 )=Revenue - Cost of Goods Sold
=197.88 - 12.468
=185.4

Gross Profit for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $701.5 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

GoodRx Holdings's Gross Margin % for the quarter that ended in Mar. 2024 is calculated as

Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=185.4 / 197.88
=93.70 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


GoodRx Holdings  (NAS:GDRX) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

GoodRx Holdings had a gross margin of 93.70% for the quarter that ended in Mar. 2024 => Durable competitive advantage


GoodRx Holdings Gross Profit Related Terms

Thank you for viewing the detailed overview of GoodRx Holdings's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


GoodRx Holdings (GoodRx Holdings) Business Description

Traded in Other Exchanges
N/A
Address
2701 Olympic Boulevard, Santa Monica, CA, USA, 90404
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers other healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
Executives
Scott Wagner officer: Interim Chief Executive Office C/O WILSON SONSINI GOODRICH AND ROSATI, 650 PAGE MILL ROAD, PALO ALTO CA 94304
Raj Beri officer: Chief Operating Officer C/O GOODRX HOLDINGS, INC., 2701 OLYMPIC BOULEVARD, SANTA MONICA CA 90404
Romin Nabiey officer: Chief Accounting Officer C/O GOODRX HOLDINGS, INC., 2701 OLYMPIC BOULEVARD, SANTA MONICA CA 90404
Andrew Slutsky officer: President & Consumer 233 WILSHIRE ROAD, SANTA MONICA CA 90410
Idea Men, Llc 10 percent owner 2701 OLYMPIC BOULEVARD, WEST BUILDING - SUITE 200, SANTA MONICA CA 90404
Karsten Voermann officer: Chief Financial Officer 233 WILSHIRE ROAD, SANTA MONICA CA 90410
Trevor Bezdek director, officer: Co-CEO 233 WILSHIRE ROAD, SANTA MONICA CA 90410
Abdiel Qualified Master Fund Lp 10 percent owner 90 PARK AVENUE, 29TH FLOOR, NEW YORK NY 10016
Douglas Joseph Hirsch director, officer: Co-CEO 233 WILSHIRE ROAD, SANTA MONICA CA 90410
Babak Azad officer: See Remarks 233 WILSHIRE ROAD, SANTA MONICA CA 90410
Bansi Nagji officer: President, Healthcare MCKESSON CORPORATION, 6555 STATE HIGHWAY 161, IRVING TX 75039
Agnes Rey-giraud director
Abdiel Capital Lp 10 percent owner C/O ABDIEL CAPITAL ADVISORS, LP, 90 PARK AVENUE, 29TH FLOOR, NEW YORK NY 10016
Abdiel Capital Advisors, Lp 10 percent owner 90 PARK AVENUE, 29TH FLOOR, NEW YORK NY 10016
Abdiel Capital Management, Llc 10 percent owner 90 PARK AVENUE, 29TH FLOOR, NEW YORK NY 10016